AAAAAA
Results:
1-12
|
Results: 12
Authors:
STASS H
DALHOFF A
KUBITZA D
SCHUHLY U
Citation: H. Stass et al., PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF ASCENDING SINGLE DOSES OF MOXIFLOXACIN, A NEW 8-METHOXY QUINOLONE, ADMINISTERED TO HEALTHY-SUBJECTS, Antimicrobial agents and chemotherapy, 42(8), 1998, pp. 2060-2065
Authors:
HOPPE JE
DALHOFF A
PFRUNDER D
Citation: Je. Hoppe et al., IN-VITRO SUSCEPTIBILITIES OF BORDETELLA-PERTUSSIS AND BORDETELLA-PARAPERTUSSIS TO BAY-12-8039, TROVAFLOXACIN, AND CIPROFLOXACIN, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1868-1868
Authors:
SCHMIDT H
DALHOFF A
STUERTZ K
TROSTDORF F
CHEN V
SCHNEIDER O
KOHLSDORFER C
BRUCK W
NAU R
Citation: H. Schmidt et al., MOXIFLOXACIN IN THE THERAPY OF EXPERIMENTAL PNEUMOCOCCAL MENINGITIS, Antimicrobial agents and chemotherapy, 42(6), 1998, pp. 1397-1401
Authors:
STASS H
DALHOFF A
Citation: H. Stass et A. Dalhoff, DETERMINATION OF BAY-12-8039, A NEW 8-METHOXYQUINOLONE, IN HUMAN-BODYFLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION USING ON-COLUMN FOCUSING, Journal of chromatography B. Biomedical sciences and applications, 702(1-2), 1997, pp. 163-174
Authors:
HERBERT S
WORLITZSCH D
DASSY B
BOUTONNIER A
FOURNIER JM
BELLON G
DALHOFF A
DORING G
Citation: S. Herbert et al., REGULATION OF STAPHYLOCOCCUS-AUREUS CAPSULAR POLYSACCHARIDE TYPE-5 - CO2 INHIBITION IN-VITRO AND IN-VIVO, The Journal of infectious diseases, 176(2), 1997, pp. 431-438
Authors:
DIMPFEL W
DALHOFF A
VONKEUTZ E
Citation: W. Dimpfel et al., IN-VITRO MODULATION OF HIPPOCAMPAL PYRAMIDAL CELL RESPONSE BY QUINOLONES - EFFECTS OF HA-966 AND GAMMA-HYDROXYBUTYRIC ACID, Antimicrobial agents and chemotherapy, 40(11), 1996, pp. 2573-2576
Authors:
DALHOFF A
PETERSEN U
ENDERMANN R
Citation: A. Dalhoff et al., IN-VITRO ACTIVITY OF BAY-12-8039, A NEW 8-METHOXYQUINOLONE, Chemotherapy, 42(6), 1996, pp. 410-425
Authors:
NITSCHE D
SCHULZE C
OESSER S
DALHOFF A
SACK M
Citation: D. Nitsche et al., IMPACT OF DIFFERENT CLASSES OF ANTIMICROBIAL AGENTS ON PLASMA ENDOTOXIN ACTIVITY, Archives of surgery, 131(2), 1996, pp. 192-199
Authors:
DALHOFF A
MATUTAT S
ULLMANN U
Citation: A. Dalhoff et al., EFFECT OF QUINOLONES AGAINST SLOWLY GROWING BACTERIA, Chemotherapy, 41(2), 1995, pp. 92-99
Authors:
DIMPFEL W
DALHOFF A
HOFMANN W
SCHLUTER G
Citation: W. Dimpfel et al., ELECTRICALLY-EVOKED POTENTIALS IN THE RAT HIPPOCAMPUS SLICE IN THE PRESENCE OF AMINOPHYLLINE ALONE AND IN COMBINATION WITH QUINOLONES, European neuropsychopharmacology, 4(2), 1994, pp. 151-156
Authors:
DALHOFF A
Citation: A. Dalhoff, QUINOLONE RESISTANCE IN PSEUDOMONAS-AERUGINOSA AND STAPHYLOCOCCUS-AUREUS - DEVELOPMENT DURING THERAPY AND CLINICAL-SIGNIFICANCE, Infection, 22, 1994, pp. 190000111-190000121
Authors:
PIDDOCK LJV
DALHOFF A
Citation: Ljv. Piddock et A. Dalhoff, SHOULD QUINOLONES BE USED IN THE TREATMENT OF BACTERIAL-INFECTIONS INNEUTROPENIC PATIENTS, Journal of antimicrobial chemotherapy, 32(5), 1993, pp. 771-774
Risultati:
1-12
|